ID
16010
Beschrijving
A Phase III Trial For Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00191152
Link
https://clinicaltrials.gov/show/NCT00191152
Trefwoorden
Versies (2)
- 02-05-16 02-05-16 -
- 26-06-16 26-06-16 -
Geüploaded op
26 juni 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00191152
Eligibility Breast Cancer NCT00191152
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
second primary malignancy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0751623
Beschrijving
brain metastases
Datatype
boolean
Alias
- UMLS CUI [1]
- C0220650
Beschrijving
peripheral neuropathy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0031117
Beschrijving
prior treatment with gemcitabine, capecitabine or taxane
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0045093
- UMLS CUI [2,1]
- C1514463
- UMLS CUI [2,2]
- C0045093
- UMLS CUI [3,1]
- C1514463
- UMLS CUI [3,2]
- C3541958
Beschrijving
active cardiac disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0018799
- UMLS CUI [1,2]
- C0205318
Beschrijving
concomitant herceptin therapy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C0338204
Similar models
Eligibility Breast Cancer NCT00191152
- StudyEvent: Eligibility
C0678222 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0045093 (UMLS CUI [2,2])
C1514463 (UMLS CUI [3,1])
C3541958 (UMLS CUI [3,2])
C0205318 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,2])